Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered Microbiome in Patients With Cirrhosis and Complications
Chathur Acharya, Jasmohan S. Bajaj
Clinical Gastroenterology and Hepatology (2018) Vol. 17, Iss. 2, pp. 307-321
Open Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Daniel M. Chopyk, Arash Grakoui
Gastroenterology (2020) Vol. 159, Iss. 3, pp. 849-863
Open Access | Times Cited: 315
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Tae Gyu Oh, Susy M. Kim, Cyrielle Caussy, et al.
Cell Metabolism (2020) Vol. 32, Iss. 5, pp. 878-888.e6
Open Access | Times Cited: 242
Homeostasis and dysbiosis of the gut microbiome in health and disease
Bhabatosh Das, G. Balakrish Nair
Journal of Biosciences (2019) Vol. 44, Iss. 5
Closed Access | Times Cited: 165
Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
Jasmohan S. Bajaj, Alexander Khoruts
Journal of Hepatology (2020) Vol. 72, Iss. 5, pp. 1003-1027
Closed Access | Times Cited: 138
Hepatic encephalopathy
Dieter Häussinger, Radha K. Dhiman, Vicente Felipo, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 132
Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis
Cristina Solé, Susie Guilly, Kévin Da Silva, et al.
Gastroenterology (2020) Vol. 160, Iss. 1, pp. 206-218.e13
Open Access | Times Cited: 128
Acute-on-chronic liver failure: A distinct clinical syndrome
Richard Moreau, Bin Gao, Mária Papp, et al.
Journal of Hepatology (2021) Vol. 75, pp. S27-S35
Closed Access | Times Cited: 95
Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
Ruipeng Zheng, Guoqiang Wang, Zhiqiang Pang, et al.
Cancer Medicine (2020) Vol. 9, Iss. 12, pp. 4232-4250
Open Access | Times Cited: 93
Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial Sepsis
Panomwat Amornphimoltham, Peter S. T. Yuen, Robert A. Star, et al.
Digestive Diseases and Sciences (2019) Vol. 64, Iss. 9, pp. 2416-2428
Closed Access | Times Cited: 92
The Role of the Gut Microbiome in Liver Cirrhosis Treatment
Na Young Lee, Ki Tae Suk
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 199-199
Open Access | Times Cited: 86
The microbiota and the gut–liver axis in primary sclerosing cholangitis
Johannes R. Hov, Tom H. Karlsen
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 3, pp. 135-154
Closed Access | Times Cited: 53
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis
Harry D Zacharias, Fady Kamel, Jaclyn Tan, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Closed Access | Times Cited: 23
Gut microbiome and metabolome signatures in liver cirrhosis-related complications
Satya Priya Sharma, Haripriya Gupta, Goo-Hyun Kwon, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 845-862
Open Access | Times Cited: 9
The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy
Jasmohan S. Bajaj, Andrew Fagan, Edith Gavis, et al.
Hepatology Communications (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 8
Chronic Liver Diseases and the Microbiome—Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease
Chathur Acharya, Jasmohan S. Bajaj
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 556-572
Open Access | Times Cited: 65
Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis
Jasmohan S. Bajaj, Nita H. Salzman, Chathur Acharya, et al.
JCI Insight (2019) Vol. 4, Iss. 24
Open Access | Times Cited: 62
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
Sally Temraz, Farah Nassar, Firas Kreidieh, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7800-7800
Open Access | Times Cited: 41
The Link between Gut Microbiota and Hepatic Encephalopathy
Sung‐Min Won, Ki‐Kwang Oh, Haripriya Gupta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8999-8999
Open Access | Times Cited: 36
Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions
Bing Yue, Yuxia Gao, Yi Hu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 7
Characterization of the circulating microbiome in acute‐on‐chronic liver failure associated with hepatitis B
Yi Zhang, Ruihong Zhao, Ding Shi, et al.
Liver International (2019) Vol. 39, Iss. 7, pp. 1207-1216
Closed Access | Times Cited: 43
Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis
Yao‐Wen Cheng, Dana Alhaffar, Srishti Saha, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 8, pp. 1627-1634
Open Access | Times Cited: 40
Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis
Antonio Riva, Elizabeth Gray, Sarah Azarian, et al.
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100151-100151
Open Access | Times Cited: 40
Epigallocatechin Gallate Can Protect Mice From Acute Stress Induced by LPS While Stabilizing Gut Microbes and Serum Metabolites Levels
Yong Ma, Gang Liu, M. Tang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33
Panax quinquefolius Polysaccharides Ameliorate Antibiotic-Associated Diarrhoea Induced by Lincomycin Hydrochloride in Rats via the MAPK Signaling Pathways
Duo-Duo Ren, Shanshan Li, Hongmei Lin, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 25
Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS
Menghao Li, Kai Li, Shihao Tang, et al.
JHEP Reports (2022) Vol. 4, Iss. 5, pp. 100448-100448
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top